Study shows potential of crucial signaling pathway as biomarker therapeutic target for cancer

Study shows potential of crucial signaling pathway as biomarker, therapeutic target for cancer

A crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted by cancer cells to put the brakes on the immune system, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.

More From BioPortfolio on "Study shows potential of crucial signaling pathway as biomarker, therapeutic target for cancer"